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Association of Serum 25-Hydroxyvitamin D Levels with Markers 
for Metabolic Syndrome in the Elderly: A Repeated Measure 
Analysis
The purpose of current study was to investigate associations of serum 25-hydroxyvitamin 
D (OHVD) levels with markers for metabolic syndrome in elderly Koreans. We conducted a 
panel study on 301 individuals over 60 yr old in Seoul, Korea, and repeatedly measured 
serum OHVD, glucose, insulin, and lipid levels. Mixed effect model and generalized 
estimating equations were used to investigate relationships between serum OHVD levels 
with marker levels for metabolic syndrome and each of its categories. Of all subjects, 
76.6% were vitamin D deficient (< 50 nM) and 16.9% were insufficient (< 75 nM). 
Inverse association was demonstrated between serum OHVD levels and insulin (P = 0.004), 
triglyceride (P = 0.023) and blood pressure (systolic blood pressure: P = 0.002; diastolic 
blood pressure: P < 0.001). Vitamin D deficiency was found to increase risk of 
‘hypertriglyceridemia’ category of metabolic syndrome (odds ratio: 1.73, 95% confidence 
interval: 1.13-2.66). In conclusion, we found from our repeated measure analysis that 
decreasing serum OHVD levels are associated with increasing insulin resistance, increasing 
serum triglyceride levels and increasing blood pressure in elderly Koreans, and confirmed 
on the risk of ‘hypertriglyceridemia’ in vitamin D deficient subjects. 
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INTRODUCTION
Concerns have been raised on hypovitaminosis D due to its high 
worldwide prevalence, and elderly population has received at-
tention in this matter as they are more prone to develop vitamin 
D deficiency than younger population. More than 90% of the 
pigmented populace in the United States (including Asians) are 
reported to have vitamin D insufficiency (50-75 nM or 20-30 
ng/mL), and estimated prevalence of vitamin D deficiency (de-
fined as  < 50 nM or  < 20 ng/mL) in elderly has been reported 
to be about 50% worldwide (1, 2). 
  The role of vitamin D in many biological systems has been 
actively researched in recent years. At the same time, insulin re-
sistance, a physiological state where insulin becomes less effec-
tive in lowering blood sugars, and metabolic syndrome, a group 
of cardiometabolic disease risk factors, has also received much 
attention for their increasing prevalence and consequent effects. 
The issue on the association of serum 25-hydroxyvitamin D 
(OHVD) levels with insulin resistance (IR) and metabolic syn-
drome (MS) has become a subject supported and challenged 
by increasing reports of evidence as well as controversy. With 
increasing reports on the role of vitamin D on elements of dia-
betes and metabolic syndrome such as adiposity, glucose ho-
meostasis, lipid profiles and blood pressure, further investiga-
tion for evidence is greatly encouraged (3-9). 
  While longitudinal studies and intervention trials have shown 
inconsistent results for the association between vitamin D and 
IR or MS, numerous cross-sectional studies have demonstrated 
in favor of the relationship. However, limitation of the study de-
signs has brought about a demand for better approach. Thus 
we carried out a panel study, as it controls time-invariant indi-
vidual characteristics by design, therefore is suitable for analyz-
ing of short-term changes in continuous variables. 
  In a national level prospective cohort study of 35,671 subjects 
followed in Korea from 2004 to 2006, significant increasing trend 
for MS was observed with increasing age (P < 0.001 for both sex) 
(10). Along with susceptibility to hypovitaminosis D, the fact 
that elderly population is more vulnerable to cardiometabolic Park HY, et al.  •  Vitamin D and Metabolic Syndrome in the Elderly
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disease risks draws attention to further examine the association 
between low serum OHVD concentration and metabolic syn-
drome in the elderly. Confirming the association would be more 
important as supplementing vitamin D is practical and uncom-
plicated, such as sunbathing and dietary modification, espe-
cially for the less-active elderly population. 
  The purpose of our study was to investigate the relationship 
of serum OHVD levels with IR and MS in elderly Koreans by re-
peated measures up to 3 times. 
MATERIALS AND METHODS
Subjects
The study is a part of the Korean Elderly Environmental Panel 
(KEEP) study on Koreans over 60 yr old residing in Seongbuk-
gu, Seoul, Republic of Korea. Of all 560 subjects, this research is 
focused on 301 subjects who had their serum OHVD levels mea-
sured more than once out of three opportunities, from August 
2008 through August 2010. 
  Four hundred and eight subjects attended initial series of vis-
its between September and December 2008, and 302 subjects 
attended second series of visits from April to September 2009. 
Third series of visits were attended by 173 subjects, between 
March to August 2010. Of the 302 subjects who made at least 
two visits, one subject was excluded as she participated from 
the second series of visits. 
Variables
A standard questionnaire was used by trained interviewers to 
collect information on age, sex, smoking (current/ex-/non-
smoker), alcohol drinking (yes/no), regular exercise (yes/no), 
and self-reported diabetes, hypertension, and dyslipidemia. A 
food frequency questionnaire on previous one year’s dietary 
intake was also carried out to calculate total (both animal and 
vegetable) calcium intake. Blood pressure after five minutes-rest, 
height and weight were measured, and venous blood samples 
were collected to measure the following: fasting blood sugar 
(FBS), insulin, triglyceride (TG), high-density lipid (HDL) cho-
lesterol, OHVD. 
  Data on moving-average amount of sunshine in Seongbuk-gu 
from the day each subject visited were gained from the Korea 
Meteorological Administration (http://www.kma.go.kr). The 
physical examination and blood test were repeated on the sec-
ond and third series of visits. 
  Insulin resistance (IR) was measured using the homeostasis 
model assessment of insulin resistance (HOMA-IR) index, which 
is calculated as [glucose × insulin]/22.50. For the definition of 
abnormal levels of the markers, we used criteria for metabolic 
syndrome according to National Cholesterol Education Program 
Adult Treatment Panel III (NCEP-ATP III) Criteria for Asian Amer-
icans: triglyceride  ≥ 1.695 mM (≥ 150 mg/dL), HDL cholesterol 
< 1.036 mM (< 40 mg/dL) for men and  < 1.295 mM (< 50 mg/
dL) for women, blood pressure  ≥ 130/85 mmHg or current use 
of antihypertensive medications, and fasting glucose  ≥ 5.55 mM 
(≥ 100 mg/dL) or previously diagnosed type 2 diabetes or using 
oral hypoglycemic agents or insulin. With lack of data for waist 
circumference, we used alternative definition of BMI  ≥ 23 kg/m
2 
instead. 
Laboratory methods
All blood samples were collected in 8 mL plain tubes around   
10 a.m. in the morning after overnight fasting and centrifuged 
within 30-60 min of collection. It was then serum-separated in 
screw cap tubes and immediately stored in -70°C freezers until 
analysis. 
  Analyses were performed in a central laboratory (Neodin 
Medical Laboratories, Seoul, Korea). Hexokinase method with 
Hitachi 7600 II analyzer (Hitachi, Tokyo, Japan) was used for 
measuring fasting blood glucose levels. Enzymatic caliometry 
was used for measuring serum lipid levels. Serum insulin levels 
were measured using competitive RIA method on 1470 WIZ-
ARD equipment (PerkinElmer, Turku, Finland), and serum 
OHVD levels were measured using chemiluminescentimmu-
noassay on LIAISON equipment (DiaSorin Inc., Stillwater, MN, 
USA). Quality control for OHVD was maintained using Levey-
Jening chart, with mean ± 2SD values set as allowable range.
Statistical analysis
Data analysis was carried out using SAS 9.2 (Cary, NC, USA) 
and R version 2.12.1 (The Comprehensive R Archive Network, 
http://cran.rproject.org). Mixed effect model was used for cal-
culating the estimate effect of log-transformed OHVD levels on 
continuous variables by multiple regression, and generalized 
estimating equation model was used to calculate the estimate 
effect of OHVD on abnormal levels of the components of MS 
(discrete variables). For the graphical analysis of relationship 
between OHVD and marker levels, we used generalized addi-
tive mixed model.
  As participants made different number of visits, the non- 
random loss of follow-up due to different number of repeated 
measures may lead to selection bias (11). Thus weighting fol-
low-up observations was carried out, by inverse probability of 
attaining a follow-up response (12). With data from participants 
who made more than one visit, we performed logistic regres-
sion to predict follow-up probability (follow-up = 1, missing = 0), 
with covariates as previously measured age, sex, BMI, number 
of years of schooling, blood pressure, season, and temperature. 
Weight value of 1 was given to first observations of each partici-
pant, and more weight was given to more likely missing obser-
vations (13). 
  For multiple regression analysis, age and sex were adjusted 
in model 1; age, sex, smoking, alcohol, exercise, diabetes, hyper-Park HY, et al.  •  Vitamin D and Metabolic Syndrome in the Elderly
http://jkms.org   655 http://dx.doi.org/10.3346/jkms.2012.27.6.653
tension and dyslipidemia were adjusted in model 2; variables 
in model 2 plus 7-days moving average for amount of sunshine 
were adjusted in model 3. In examining the association between 
OHVD levels and each of MS components, we used the same 
models.
Ethics statement
The study protocol was approved by the institutional review 
board of Seoul National University Hospital (IRB No. H-0804-
045-241). Written informed consent was received from all par-
ticipants.
RESULTS
Baseline characteristics of study subjects are shown in Table 1. 
Of the 301 subjects, 68 were male and 233 were female, and their 
average age was 70.4 ± 5.23 (range: 60-84 yr). Percentages for 
current smoking and alcohol drinking were very low (smoking: 
6.0%, alcohol drinking: 17.6%) while percentage of subject pop-
ulation on regular exercise was relatively high (38.4%). 
  Mean serum OHVD level was 41.66 ± 19.436 nM, ranging 
from 5.0 to 159.0 nM. Of all the measurements, 76.6% fell under 
vitamin D deficiency (< 50 nM) while 16.9% and 6.6% fell under 
insufficiency (50-75 nM) and sufficiency (> 75 nM). Percentag-
es of subjects having hypertension, diabetes and dyslipidemia 
were derived from questionnaire results, and were found to be 
45.5%, 16.0%, and 11.3% respectively.
  Serum OHVD levels were calculated in percentiles and di-
vided into quartiles, as Q1 (< 20.754 nM), Q2 (20.754-32.448 nM), 
Q3 (32.448-48.298 nM), and Q4 (≥ 48.298 nM). Characteristics 
of study subjects across quartiles of OHVD levels on all three 
visits are described in Table 2. For mean and standard deviation 
values for each variable across quartiles of OHVD levels, P values 
were significant for body mass index (BMI), SBP, DBP, triglycer-
ide (TG) levels, HOMA-IR, and amount of sunshine of the study 
area on the day each subject visited. Significant difference across 
quartiles of OHVD levels were also observed with subjects’ smok-
ing, alcohol drinking and regular exercise. 
  Numbers and their percentages of subjects for abnormal cat-
egories of components for metabolic syndrome across quartiles of 
serum OHVD levels are shown in Table 3. Mantel-Haenszel chi-
square test for trend showed significant difference in hypertriglyc-
eridemia and hypertension across quartiles of OHVD levels.
  Effects of serum OHVD levels on continuous variables (BMI, 
TG, HDL cholesterol, glucose, insulin, HOMA-IR, SBP, and DBP) 
across differently adjusted models were analyzed by mixed model 
Table 1. Baseline characteristics of study subjects by gender 
Parameters
All Male Female
P value
No./mean %/SD No./mean %/SD No./mean %/SD
No. (%) 301 68 233
Age (yr) 70.4 5.23 71.5 4.29 70.1 5.45 0.022
Body mass index (kg/m
2) 24.72 2.950 24.04 3.068 24.91 2.893 0.524
Systolic blood pressure (mmHg) 133.3 17.85 131.7 20.37 133.7 17.06 0.059
Diastolic blood pressure (mmHg) 75.3 10.64 75.1 11.66 75.3 10.35 0.206
Vitamin D (nM) 41.658  19.436  51.218  18.034  38.863  18.975  0.633
Triglyceride (mM/L) 1.558  0.943  1.532  1.038  1.566  0.916  0.184
HDL cholesterol (mM/L) 1.279  0.316  1.204  0.352  1.300  0.302  0.103
Glucose (mM/L) 5.261  1.222  5.356  1.282  5.228  1.204  0.495
Insulin (pM/L) 51.230  38.207  44.342  32.754  53.239  39.498  0.072
HOMA-IR 31.5 27.828 27.54 22.86 32.58 29.07 0.021
Calcium intake (mM/d) 17.92 8.1675 18.865 8.3325 17.6575 8.1225 0.781
Total amount of sunshine (hr)
   lag 0 
   lag 0-1 
   lag 0-7 
   lag 0-14 
 
5.6
5.8
6.0
6.4
 
3.88
4.01
3.77
3.50
 
5.9
5.7
5.8
5.9
 
3.73
4.38
4.16
3.60
 
5.5
5.8
6.0
6.6
 
3.92
3.91
3.66
3.47
 
0.627
0.221
0.170
0.666
Daily mean temperature (°C)
   lag 0 
   lag 0-1 
   lag 0-7 
   lag 0-14 
 
15.3
15.5
15.2
16.1
 
9.42
8.87
9.63
9.74
 
16.6
17.0
16.7
18.2
 
9.69
8.83
8.64
8.80
 
14.8
15.1
14.7
15.6
 
9.32
8.86
9.88
9.94
 
0.665
1
0.194
0.237
Smoking (%) 18 6.0 17 25 1 0.4 < 0.001
Alcohol drinking (%) 53 17.6 32 47.1 21 9.0 < 0.001
Regular exercise (%) 183 61.6 38 55.9 145 63.3 0.269
Hypertension (%) 137 45.5 35 51.5 102 43.8 0.263
Diabetes (%) 48 16.0 12 17.7 36 15.5 0.664
Dyslipidemia (%) 34 11.3 8 11.8 26 11.2 0.890
HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance index.Park HY, et al.  •  Vitamin D and Metabolic Syndrome in the Elderly
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Table 2. Characteristics of study subjects across quartiles of serum OHVD levels, over all visit periods combined
Parameters
Q1:  
< 20.754 nM
Q2:  
20.754-32.448 nM
Q3:  
32.448-48.298 nM
Q4:  
≥ 48.298 nM  P value
No./mean %/SD No./mean %/SD No./mean %/SD No./mean %/SD
No. (%) 194 193 195 194
Age (yr) 72.0 5.63 71.8 5.77 70.2 5.01 71.3 4.77 0.004
Female sex (%) 171 87.69 158 81.87 144 73.85 134 69.07 < 0.001
Body mass index (kg/m
2) 24.83 3.104 25.28 3.094 24.85 2.869 24.07 2.706 0.001
Systolic blood pressure (mmHg) 132.6 16.92 131.1 17.01 130.8 17.14 126.1 17.68 0.002
Diastolic blood pressure (mmHg) 74.8 10.99 74.2 10.40 73.8 10.25 71.0 9.90 0.002
Triglyceride (mM/L) 1.64  0.950  1.57  0.944  1.43  0.748  1.43  0.812  0.031
HDL cholesterol (mM/L) 1.34  0.354  1.33  0.326  1.32  0.333  1.33  0.359  0.934
Glucose (mM/L) 5.59  1.267  5.60  1.564  5.44  1.377  5.37  1.063  0.246
Insulin (pM/L) 60.84  79.470  62.42  64.310  52.09  37.489  48.79  40.675  0.055
HOMA-IR 40.68 62.514 43.2 61.956 32.94 28.962 31.14 34.092 0.044
Calcium intake (mM/d) 15.763 6.345 19.3 8.371 16.795 8.634 18.828 8.005 0.091
Total amount of sunshine (hr)
   lag 0 
   lag 0-1 
   lag 0-7 
   lag 0-14 
 
5.7
5.5
6.2
5.9
 
4.24
4.20
4.31
4.09
  
5.6
5.3
5.7
5.9
 
4.22
4.03
4.14
4.24
 
5.1
5.6
5.5
5.9
 
4.10
4.35
4.08
3.81
 
4.8
5.3
5.8
5.9
 
4.00
4.10
3.90
3.84
 
0.167
0.869
0.372
0.999
Daily mean temperature (°C)
   lag 0 
   lag 0-1 
   lag 0-7 
   lag 0-14
 
12.7
12.9
11.8
10.6
 
7.62
7.21
7.52
7.82
 
15.8
15.8
15.3
14.4
 
8.05
8.14
8.33
9.38
 
17.9
18.1
17.9
17.8
 
8.65
8.17
8.48
8.50
 
18.5
18.8
18.3
18.3
 
8.35
7.90
9.18
8.82
 
< 0.001
< 0.001
< 0.001
Current smoking (%) 5 2.6 10 5.2 8 4.1 23 11.9 0.004
Current drinking (%) 23 11.8 34 17.6 37 19.0 44 22.7 0.006
No regular exercise (%) 135 67.0 112 59.3 114 59.7 108 55.7 0.007
Hypertension (%) 94 48.2 87 45.1 94 48.2 78 40.2 0.192
Diabetes (%) 25 12.8 33 17.1 26 13.3 39 20.1 0.123
Dyslipidemia (%) 19 9.7 18 9.3 19 9.7 34 17.5 0.021
HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance index.
Table 3. “Positive” or “negative” proportions in five categories of metabolic syndrome; in total number of measurements, across quartiles of serum OHVD levels
Categories of 
   metabolic syndrome
Total  
number of  
measurements
 Number of subjects distributed over quartiles of OHVD levels
 P value
Q1:  
< 20.754 nM
Q2:  
20.754-32.448 nM
Q3:  
32.448-48.298 nM
Q4:  
≥ 48.298 nM
 No. %  No. %  No. %  No. %  No. %
Body mass index (kg/m
2)
   < 23 
   ≥ 23
 
203
574
 
26.13
73.87
 
  50
145
 
25.64
74.36
 
  47
146
 
24.35
75.65
 
  43
152
 
22.05
77.95
 
  63
131
 
32.47
67.53
 
 0.198
Triglyceride (mM/L)
   < 1.695 
   ≥ 1.695
 
532
245
 
68.47
31.53
 
123
  72
 
63.08
36.92
 
131
  62
 
67.88
32.12
 
131
  64
 
67.18
32.82
 
147
  47
 
75.77
24.23
  
 0.012
HDL cholesterol
   ≥ 1.036 mM/L (men) or 
   ≥ 1.295 mM/L (women)
   < 1.036 mM/L (men) or 
   < 1.295 mM/L (women)
 
448
  
329
 
57.66
 
42.34
 
106
 
  89
 
54.36
 
45.64
 
112
 
  81
 
58.03
 
41.97
 
116
 
  79
 
59.49
 
40.51
 
114
 
  80
 
58.76
 
41.24
 
 0.354
Hypertensive
   < 130/85 mmHg
   ≥ 130/85 mmHg or 
     currently in medication
 
226
551
 
29.09
70.91
 
  48
147
 
24.62
75.38
 
  53
140
 
27.46
72.54
 
  49
146
 
25.13
74.87
 
  76
118
 
39.18
60.82
 
 0.005
Diabetic
   FBS < 5.55 mM/L
   FBS ≥ 5.55 mM/L or 
      using oral medication/insulin 
      or previously diagnosed T2DM
 
512
265
 
65.89
34.11
 
118
  77
 
60.51
39.49
 
124
  69
 
64.25
35.75
 
139
  56
 
71.28
28.72
 
131
  63
 
67.53
32.47
 
 0.065
HDL cholesterol, high-density lipoprotein cholesterol.Park HY, et al.  •  Vitamin D and Metabolic Syndrome in the Elderly
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analysis, and are shown in Table 4. Significant inverse relation-
ship with serum OHVD levels were found with TG, insulin, 
HOMA-IR, SBP and DBP across all three models, but no signifi-
cance was found with BMI, HDL cholesterol and glucose in any 
of the models. Results were consistent in direction and signifi-
cance across all the selected moving average for amount of sun-
shine, and the effect size was greatest at lag 0-7. To confirm for 
the linear association between log-transformed OHVD levels 
and various outcome variables in the mixed model analysis, we 
implemented generalized additive mixed models, as shown in 
Fig. 1 (14). 
  Effects of OHVD levels on categorical variables of MS com-
ponents across differently adjusted models were analyzed by 
generalized estimating equations. From analysis of outcome 
variables across all quartiles of OHVD levels, highest odds ratios 
Table 4. Multiple regression of serum OHVD levels on measured outcome variables and HOMA-IR
Variables
Model 1* Model 2
† Model 3
‡
Estimate (β) SE P value Estimate (β) SE P value Estimate (β) SE P value
Body mass index -0.09605 0.08722 0.271 -0.1004 0.0875 0.252 -0.09148 0.0886 0.302
Triglyceride -6.9665 3.4221 0.042 -7.1769 3.4575 0.036 -7.9583 3.493 0.023
HDL cholesterol 0.2381 0.5905 0.687 0.2028 0.5949 0.733 0.2429 0.6019 0.687
Glucose 0.1045 1.1383 0.927 -0.5828 1.0936 0.594 -0.6291 1.1062 0.570
Insulin -1.1679 0.456 0.011 -1.3329 0.4565 0.004 -1.3507 0.4614 0.004
HOMA-IR -0.3361 0.1574 0.033 -0.4179 0.1553 0.007 -0.4238 0.1569 0.007
Systolic blood pressure -2.6426 0.8234 0.001 -2.4871 0.8257 0.003 -2.5667 0.8347 0.002
Diastolic blood pressure -2.2071 0.5092 < 0.001 -2.1305 0.5124 < 0.001 -2.1463 0.5184 < 0.001
*Model 1, adjusted for age and sex. 
†Model 2, adjusted for age, sex, smoking, alcohol, exercise, diabetes, hypertension and dyslipidemia. 
‡Model 3, adjusted for all variables in 
model 2 plus 7-day moving average for amount of sunshine of Seongbuk-gu from the day each subject visited. HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, 
homeostasis model assessment of insulin resistance index.
Fig. 1. Association between log-transformed OHVD levels and various outcome variables by generalized additive mixed models adjusted for age, sex, smoking, drinking, regular 
exercise, diabetes, hypertension, dyslipidemia, 7-day moving average for sunshine amount of Seongbuk-gu from the day each subject visited. BMI, body mass index; TG,  
triglyceride; HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance index; SBP, systolic blood pressure; DBP,   
diastolic blood pressure; log(25(OH)D), log-transformed 25-hydroxyvitamin D.
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for significant variables were estimated at the 75th percentile 
level of 48.298 nM (data not shown). As 50 nM is the definition 
level for vitamin D deficiency and as odds ratios at 48.298 nM 
and 50 nM did not largely differ, we evaluated the estimate ef-
fect of vitamin D at 50 nM on abnormal levels of markers. Table 5 
shows odds ratios of OHVD deficiency level on abnormal levels 
of markers across adjusted models. At serum OHVD level of 50 
nM, odds ratios and their 95% confidence intervals were signifi-
cant with only hypertriglyceridemia category of MS, with simi-
lar effect size across all models (odds ratio [OR]: 1.74 [95% con-
fidence interval: 1.13-2.70] in model 3). 
DISCUSSION
Our results showed statistically significant inverse association of Park HY, et al.  •  Vitamin D and Metabolic Syndrome in the Elderly
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OHVD levels with IR, TG and blood pressure. Subjects with se-
rum OHVD level less than 50 nM showed increased odds ratio 
of 1.74 for hypertriglyceridemia when we used criteria for MS. 
  Average serum OHVD level found in our study was 41.66 nM 
and proportion of vitamin D deficiency (< 50 nM) was 76.6%. 
These results are comparable with a population-based cross-
sectional study on middle-aged and elderly Chinese popula-
tion, which showed that their average OHVD level was 16.19 ng/ 
mL (40.41 nM) with deficiency proportion of 69.2% (6). Another 
cross-sectional study on elderly Spanish found average as 17.21 
ng/mL (42.96 nM) and proportion of OHVD level below 25 ng/
mL (62 nM) as 86% (15). A cohort study on population over 30 yr 
old (mean age 49.6) with high risk for type 2 diabetes and/or MS 
found the average level as 22.36 ng/mL (55.81 nM) (16); the slight-
ly higher average level of OHVD in the study could be explained 
by younger age-distribution of the study population. The lower 
serum OHVD levels in the elderly is possibly due to specific phys-
iological and lifestyle factors linked to advanced age, such as 
impaired production of 7-dehydrocholesterol in the skin, insuf-
ficient exposure to sunlight, poor dietary intake of vitamin D, as 
well as chronic diseases, pharmacological treatments and dis-
ability (17).
  Associations of serum OHVD levels and serum lipids have 
been reported. The Tromsø study in Norway showed significant 
increase in total cholesterol, HDL cholesterol and LDL choles-
terol levels and decrease in serum TG levels across increasing 
serum OHVD quartiles in cross-sectional study, but significant 
association was found with serum TG levels only in longitudi-
nal study (18). Other cross-sectional studies also supported the 
association of OHVD levels and lipid levels, but significance was 
confirmed with TG levels only (19, 20).
  Our results on OHVD levels and insulin or HOMA-IR showed 
clear inverse relationship, and conforms with previous studies 
that used HOMA-IR as a marker to indicate IR. Numerous cross-
sectional studies, with subjects in varying age group, in non-di-
abetic status or in risk of diabetes and/or MS and in various con-
founder-adjusted models, reported significant association with 
low serum OHVD levels and insulin resistance (16, 21-26). In a 
prospective study on non-diabetic subjects aged 40-69 yr, base-
line OHVD level was inversely associated with 10-yr risk of 2-hr 
glucose, insulin, and HOMA-IR (22). 
  Recently reported studies favor our finding on the relation-
ship of OHVD levels with blood pressure. In a meta-analysis in-
cluding 4 prospective studies and 14 cross-sectional studies, the 
odds ratio for a 16 ng/mL or 39.94 nM (2 SD) increment in se-
rum OHVD level was 0.84 (95% CI 0.78-0.90) (27). The same 
study group also performed a cross-sectional study where they 
measured supine and 24-hr blood pressure measurements to 
lessen classification bias. Their results showed that men with 
OHVD levels  < 15.02 ng/mL or  < 37.49 nM had a 3-fold higher 
prevalence of hypertension compared to those with  ≥ 15.02 
ng/mL or  ≥ 37.49 nM (28). In another recent study on initially 
normotensive, middle-aged Koreans with median OHVD level 
of 46.8 nM, odds ratio was substantially higher for new hyper-
tension after 4 yr in subjects with OHVD levels below the medi-
an value compared with those above median (OR 2.74; 95% CI 
1.40-5.34) (29). 
  Relationship between OHVD levels and insulin, HOMA-IR, 
SBP, DBP as continuous variables in our study showed statisti-
cal significance, but relationship between OHVD levels and ‘hy-
pertensive’ , ‘diabetic’ categories of MS did not. The latter insig-
nificant results could be explained by the different value char-
acteristics: serum OHVD, FBS levels and blood pressure reflect 
changes on daily basis while the ‘hypertensive’ and ‘diabetic’ 
Table 5. Effect of serum OHVD levels on five categories of MS at definition level for vitamin D deficiency (50nM) 
Model/variables Estimate (β) SE 95% CI P value OR 95% CI
Model 1*
   Body mass index
   Triglyceride
   HDL cholesterol
   Hypertensive
   Diabetic
 
-0.0482
0.5498
-0.2177
0.2617
-0.0207
 
0.188
0.2193
0.1709
0.1887
0.155
 
-0.4166
0.1201
-0.5528
-0.1083
-0.3245
 
0.3202
0.9796
0.1173
0.6316
0.283
 
0.797
0.012
0.203
0.166
0.894
 
0.95
1.73
0.80
1.30
0.98
 
0.66
1.13
0.58
0.90
0.72
 
1.38
2.66
1.12
1.88
1.33
Model 2
†
   Body mass index
   Triglyceride
   HDL cholesterol
   Hypertensive
   Diabetic
 
-0.0669
0.5565
-0.2065
0.2821
0.0245
 
0.192
0.2209
0.1734
0.1959
0.1582
 
-0.4432
0.1235
-0.5462
-0.1019
-0.2856
 
0.3093
0.9895
0.1333
0.6661
0.3347
 
0.727
0.012
0.234
0.150
0.877
 
0.94
1.74
0.81
1.33
1.02
 
0.64
1.13
0.58
0.90
0.75
 
1.36
2.69
1.14
1.95
1.40
Model 3
‡
   Body mass index
   Triglyceride
   HDL cholesterol
   Hypertensive
   Diabetic
 
-0.0652
0.5488
-0.2126
0.2857
0.0236
 
0.1928
0.2196
0.1757
0.1952
0.1584
 
-0.4431
0.1184
-0.5569
-0.0969
-0.2869
 
0.3126
0.9791
0.1318
0.6682
0.334
 
0.735
0.012
0.226
0.143
0.882
 
0.94
1.73
0.81
1.33
1.02
 
0.64
1.13
0.57
0.91
0.75
 
1.37
2.66
1.14
1.95
1.40
*Model 1, adjusted for age and sex. 
†Model 2, adjusted for age, sex, smoking, alcohol and exercise. 
‡Model 3, adjusted for all variables in model 2 plus 7-day moving average 
for sunshine amount of Seongbuk-gu from the day each subject visited. HDL cholesterol, high-density lipoprotein cholesterol.Park HY, et al.  •  Vitamin D and Metabolic Syndrome in the Elderly
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categories reflect changes on longer term basis, as diabetes and 
hypertension are disease states attained possibly through years 
(i.e. not easily changed over time). Another possible explana-
tion for the disappeared significance is that the effect of hypovi-
taminosis D may not be as influential as to reach body’s “thresh-
old” at which diabetes or hypertension can be developed. Al-
though insignificant, increased odds ratios of ‘hypertensive’ and 
‘diabetic’ categories at vitamin D deficiency level support the 
assumption (‘hypertensive’: OR 1.33, 95% CI: 0.91-1.95; ‘diabet-
ic’: OR 1.02, 95% CI: 0.75-1.40).  
  Because another Korean study suggested that the relationship 
between vitamin D and the risk of hypertension might be asso-
ciated with a low habitual calcium intake and a high prevalence 
of vitamin D deficiency in Korea (29), we also analyzed for sig-
nificance of total calcium intake across quartiles of OHVD lev-
els by ANOVA (Table 2), and found no significant association. 
However, we could not further investigate this association in the 
mixed effects or generalized estimating equation model analy-
ses, as calcium intake measurement was taken only once. 
  To our knowledge, this is the first study that has performed a 
repeated measure analysis in investigating the effect of OHVD 
levels on IR and MS. The advantage of this approach over exist-
ing cross-sectional analyses is to provide increased power to the 
outcome association. In mixed models, intra-individual varia-
tion as well as inter-individual variation is taken into account, 
thus providing increased validity for the association. However, 
it must also be noted that repeated measure analysis is limited 
in deducing causality. 
  Our study has several limitations. We did not account for para-
thyroid hormone (PTH) levels. With the role of OHVD/PTH axis 
as maintaining extracellular calcium homeostasis, PTH levels 
may play a role for the effect of OHVD. However, effects of PTH 
levels on IR or MS still remains a controversy as the previous  
results have been inconsistent. In one study, researchers found 
MS positively related to PTH levels in older men but not in wom-
en (9), while other found no evidence of independent associa-
tion between PTH levels and MS (5). Another study reported 
results favoring PTH and not OHVD levels as an independent 
predictor of MS, but results were limited to morbidly obese Cau-
casians (30). A more recent study showed inconsistent associa-
tions of PTH levels with IR and MS across different OHVD levels 
(26). In the study on middle-aged Koreans, serum PTH and cal-
cium levels were significantly higher in subjects with MS com-
pared with those without, but the association of serum vitamin 
D levels and MS/hypertension were unchanged after adjustment 
for PTH and serum calcium levels, indicating that the associa-
tions were independent of these factors (29). 
  Although we adjusted for regular exercise and moving aver-
age of sunshine amount on days each subject visited, it would 
have been more accurate if we adjusted for actual outdoor phys-
ical activity and exposure amount to sunshine. Also, although 
oral vitamin D supplements are not available in Korea, we did 
not account for additional measures of vitamin D-rich food in-
take.
  To allow for ethnicity, we used updated NCEP-ATP III criteria 
for Asian Americans for definition of MS. However, we used cal-
culated BMI instead of waist circumference. Threshold level of 
23 kg/m
2 was used as this is the level classified as “overweight” 
in Asian populations (31). Waist circumference measurements 
in elderly could be inaccurate; nonetheless, BMI is less reflec-
tive of central obesity than waist circumference. Each subjects’ 
visit dates were on different intervals and seasons. To compen-
sate for possible bias effect due to different seasons, we adjust-
ed 7-days moving average for total amount of sunshine on each 
visit date in the final model. 
  In conclusion, we have found from our repeated measure 
analysis that decreasing OHVD levels are associated with in-
creasing insulin resistance, increasing serum triglyceride levels 
and increasing blood pressure in elderly Koreans, and confirmed 
on the risk of ‘hypertriglyceridemia’ in vitamin D deficient sub-
jects. 
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